165 related articles for article (PubMed ID: 31174180)
1. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Nema R; Patel P; Kumar A
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
[TBL] [Abstract][Full Text] [Related]
4. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
5. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
[TBL] [Abstract][Full Text] [Related]
6. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
[TBL] [Abstract][Full Text] [Related]
7. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Parker BA; Shatsky RA; Schwab RB; Wallace AM; ; Wolf DM; Hirst GL; Brown-Swigart L; Esserman LJ; van 't Veer LJ; Ghia EM; Yau C; Kipps TJ
Breast Cancer Res Treat; 2023 Jun; 199(2):281-291. PubMed ID: 37029329
[TBL] [Abstract][Full Text] [Related]
8. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
Heabah NAE; Darwish SA; Eid AM
Pathol Res Pract; 2023 Aug; 248():154703. PubMed ID: 37481855
[TBL] [Abstract][Full Text] [Related]
10. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
[TBL] [Abstract][Full Text] [Related]
11. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.
Desnoyers A; González C; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
Mol Diagn Ther; 2020 Apr; 24(2):143-151. PubMed ID: 32100239
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of rat Ror1 and Ror2 genes in silico.
Katoh M; Katoh M
Int J Mol Med; 2005 Mar; 15(3):533-8. PubMed ID: 15702250
[TBL] [Abstract][Full Text] [Related]
13. Targeting ROR1 identifies new treatment strategies in hematological cancers.
Karvonen H; Niininen W; Murumägi A; Ungureanu D
Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomics on ROR1 and ROR2 orthologs.
Katoh M; Katoh M
Oncol Rep; 2005 Nov; 14(5):1381-4. PubMed ID: 16211313
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
Shabani M; Naseri J; Shokri F
Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
[TBL] [Abstract][Full Text] [Related]
16. Expression of ROR1 has prognostic significance in triple negative breast cancer.
Chien HP; Ueng SH; Chen SC; Chang YS; Lin YC; Lo YF; Chang HK; Chuang WY; Huang YT; Cheung YC; Shen SC; Hsueh C
Virchows Arch; 2016 May; 468(5):589-95. PubMed ID: 26874851
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans.
Yoda A; Oishi I; Minami Y
J Recept Signal Transduct Res; 2003 Feb; 23(1):1-15. PubMed ID: 12680586
[TBL] [Abstract][Full Text] [Related]
18. ROR1 and ROR2 expression in pancreatic cancer.
Liu D; Sharbeen G; Phillips P; ; Ford CE
BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
[TBL] [Abstract][Full Text] [Related]
19. ROR1 and ROR2-novel targets for neuroblastoma.
Dave H; Butcher D; Anver M; Bollard CM
Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
[No Abstract] [Full Text] [Related]
20. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development.
Al-Shawi R; Ashton SV; Underwood C; Simons JP
Dev Genes Evol; 2001 Apr; 211(4):161-71. PubMed ID: 11455430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
